Subtype
Malignant Anorectal Neoplasm
CI-CAN-00005864Explore in graph →
452 active trials1 approved drugs6 evidence items
- NCIt
- C215225
Loading cancer entity…
Subtype
CI-CAN-00005864Explore in graph →
Clinical trials
1,783 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (174)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00738790 | Preoperative Radiotherapy and Local Excision in Rectal Cancer | unknown | Phase 3 | 102 | Polish Colorectal Cancer Study GroupNETWORK | 1 | Apr 15, 2010 | clinicaltrials |
| NCT00833131 | The Randomised Study of Preoperative Radiotherapy With Consolidating Chemotherapy for Unresectable Rectal Cancer | unknown | Phase 3 | 540 | Polish Colorectal Cancer Study GroupNETWORK | 1 | Apr 15, 2010 | clinicaltrials |
| NCT01060501 | Modulation of Adjuvant 5-FU by Folinic Acid and Interferon-alpha in Colon Cancer(FOGT1) | completed | Phase 3 | 796 | University of UlmOTHER | 1 | Feb 2, 2010 | clinicaltrials |
| NCT00467922 | An Assessment of Goal-Directed Intraoperative Fluid Management in Hand Assisted Laparoscopic Colectomy | completed | Phase 3 | 69 | Corewell Health WestOTHER | 1 | Oct 21, 2009 | clinicaltrials |
| NCT00337389 | Phase III Randomized Study of 5-FU, CoFactor, and Avastin vs. 5-FU, LV and Avastin for First-Line Colorectal Cancer. | unknown | Phase 3 | 1,200 | Mast Therapeutics, Inc.INDUSTRY | 2 | Nov 19, 2007 | clinicaltrials |
| NCT00189657 | 5FU/VL Vs LV5FU2 + CPT11 in Stage II-III Resected Rectal Cancer | unknown | Phase 3 | — | Association Européenne de Recherche en OncologieOTHER | 1 | Sep 19, 2005 | clinicaltrials |
Data updated 22 days agoSource updated Apr 15, 2010source: clinicaltrials